Advertisement
News
Advertisement

pSivida partner to get $40M to develop Iluvien

Wed, 07/18/2012 - 12:00am
Mass High Tech: The Journal of New England Technology

A partner of Watertown-based pSivida Corp. (Nasdaq:PSDV), which makes drug delivery products for treatment of back-of-the-eye diseases, will get $40 million in equity. PSivida partner Alimera Sciences will use the financing to develop Iluvien, its treatment for diabetic macular edema (DME).

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading